No Data
No Data
Fertility Pioneer and Kindbody Founder Gina Bartasi Returns as CEO to Lead Company's Next Phase of Growth
Express News | Progyny Outlook FY Revenue USD 225-250 Million
Progyny, Inc. to Present at Jefferies Global Healthcare Conference
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Pete Anevski, Progyny's Chief Executive
Progyny's (NASDAQ:PGNY) Performance Is Even Better Than Its Earnings Suggest
Investors were underwhelmed by the solid earnings posted by Progyny, Inc. (NASDAQ:PGNY) recently. We did some digging and actually think they are being unnecessarily pessimistic. NasdaqGS:PGNY Ear
Progyny:Bd of Directors Approved Shr Repurchase Up to $100M of Common Stk, Follows Program Announced Feb 29 >PGNY
Progyny:Bd of Directors Approved Shr Repurchase Up to $100M of Common Stk, Follows Program Announced Feb 29 >PGNY
Express News | Progyny Announces $100M Share Repurchase Program Approved By Board Of Directors; To Be Funded Through Available Cash Balances